Robert F. Kennedy Jr., one of President-elect Donald Trump’s advisers on health, is taking aim at the FDA’s oversight on many fronts. How much influence Kennedy will have in Trump’s administration remains unclear. Here’s what to know. https://t.co/ba5G8cxkOF pic.twitter.com/w60XXOZ0a5
— The New York Times (@nytimes) November 12, 2024
Categories